Top compounds associated with response to CDCA2


Feature Type Standardized
Nominal ANOVA
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA FK866 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.13 7e-05
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.13 9e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA clofarabine CTRPv2 pan-cancer AAC 0.11 0.0001
mRNA Rapamycin gCSI pan-cancer AAC 0.2 0.0002
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.11 0.0002
Download CSV